Relationship between background cancer pain, breakthrough pain, and analgesic treatment: a preliminary study for a better interpretation of epidemiological and clinical studies

By Mercadante Sebastiano  

Current Medical Research and Opinion, Vol. 29, Iss. 6, 2013-06 ,pp. : 667-671

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain

By Rauck Richard L.   Tark Marvin   Reyes Eva   Hayes Teresa G.   Bartkowiak Anthony J.   Hassman David   Nalamachu Srinivas   Derrick Rob   Howell Julian  

Current Medical Research and Opinion, Vol. 25, Iss. 12, 2009-12 ,pp. : 2877-2885

Informa Healthcare

Access to resources Recommend Favorite

Long-term effectiveness and tolerability of sublingual fentanyl orally disintegrating tablet for the treatment of breakthrough cancer pain

By Nalamachu Srinivas   Hassman David   Wallace Mark S.   Dumble Sam   Derrick Rob   Howell Julian  

Current Medical Research and Opinion, Vol. 27, Iss. 3, 2011-03 ,pp. : 519-530

Informa Healthcare

Access to resources Recommend Favorite

Fentanyl for Breakthrough Cancer Pain: Where are We?

By  

Reviews on Recent Clinical Trials, Vol. 8, Iss. 1, 2013-03 ,pp. : 42-47

Bentham Science Publishers

Access to resources Recommend Favorite

A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trial

By Mercadante S.   Radbruch L.   Davies A.   Poulain P.   Sitte T.   Perkins P.   Colberg T.   Camba M.A.  

Current Medical Research and Opinion, Vol. 25, Iss. 11, 2009-11 ,pp. : 2805-2815

Informa Healthcare

Access to resources Recommend Favorite